• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Advisory Committees

  • Print
  • Share
  • E-mail

Roster of the Molecular and Clinical Genetics Panel

Purpose: The Committee reviews and evaluates data concerning the safety and effectiveness of marketed and investigational in vitro devices for use in clinical laboratory medicine including clinical and molecular genetics and makes appropriate recommendations to the Commissioner of Food and Drugs.

Applying for Membership on FDA Advisory Committees

As part of the Food and Drug Administration's (FDA's) ongoing efforts to recruit qualified experts with minimal conflicts of interest who are interested in serving on FDA advisory committees, FDA is requesting nominations for members to serve on its advisory committees.

Current Number of Vacancies: 0

Note, one or more vacancies may be in the nomination process or a final appointment may have been made.

Ronald M. Przygodzki, M.D.

Expertise:  Molecular Genetics
Term:  02/10/2014 – 05/31/2017
Acting Director, Biomedical Laboratory
Research & Development
Dept. of Veterans Affairs, Office of Research & Development
810 Vermont Ave., NW (121E)
Washington, DC  20420
Designated Federal Official
Jamie Waterhouse
Center for Devices and Radiological Health
Office of Device Evaluation
10903 New Hampshire Ave.
WO Bldg. 66, Room #1544
Silver Spring, MD  20993
Phone:  301-796-3063
Fax:  301-847-8122

Christopher M. Cunniff, M.D.
Expertise: Pediatrics; Human Genetics
Term: 05/09/2013-05/31/2016
Professor, Dept. of Pediatrics
Section of Medical and Molecular Genetics
University of Arizona
1451 North Warren ST. Room 101
Tucson, AZ 85724

Luis F. Escobar, MD
Expertise: Medical Genetics; Neonatology
Term:  02/10/2014 – 05/31/2017
Medical Director - Staff Neonatologist
Medical Genetics and Neurodevelopmental Center
St. Vincent Hospital and Health Services
8402 Harcourt Rd.  Suite 300
Indianapolis, IN 46260

David B. Flannery, M.D.
Expertise:  Medical Genetics; Pediatrics
Term:  06/01/2011 - 05/31/2015
Professor of Pediatrics
Chief, Section of Medical Genetics
Department of Pediatrics
Medical College of Georgia
1120 15th St., Room BG-1071
Augusta, GA 30912

*Patricia Ann Furlong, BSN, M.S.
Expertise:  Neuromuscular Disorders
Term:  02/14/2012 - 05/31/2015
Founding President and CEO
Parent Project Muscular Dystrophy
1052 North University
Middletown, OH 45042


**David W. Gates, Ph.D.
Expertise: Regulatory Affairs
Term: 05/15/2013-05/31/2016
Senior Director Regulatory Affairs
Roche Molecular Systems, Inc.
4300 Hacienda Dr.
Pleasanton, CA 94588

Richard D. Press, M.D., Ph.D.
Expertise: Molecular Diagnostics
Term:  09/09//2014 to 05/31/2018
Medical Director, Molecular Diagnostics
Dept. of Pathology, L113
Oregon Health & Science University
3181 SW Sam Jackson Park Road
Portland, OR 97201

Erasmus Schneider, Ph.D.
Expertise: Molecular Diagnostics
Term:  9/09/2014 to 05/31/2018
Director, Division of Translational Medicine
Wadsworth Center -New York State Dept. of Health
Empire State Plaza
Biggs Laboratories C345
Albany, NY  12201

Karen E. Weck, M.D.
Expertise:  Molecular Genetics; Human Genetics
Term:  06/01/2011 - 05/31/2015
Director Molecular Genetics
Dept. of Pathology & Lab Medicine
Univ. of North Carolina School of Medicine
101 Manning Drive, Campus Box 7525
Chapel Hill, NC  27599-7525
 *Consumer Representative
**Industry Representative